Det er ukendt i hvilken grad denne nedsættelse af hæmoglobinværdier skyldtes den underliggende prostatakræft, og i hvilken grad det var en konsekvens af androgen deprivationsbehandling.
It is unknown to what extent this decrease in haematological values was caused by the underlying prostate cancer and to what extent it was a consequence of androgen deprivation therapy.